Your browser doesn't support javascript.
loading
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease.
Bradshaw, Daniel; Abramowicz, Iga; Bremner, Stephen; Verma, Sumita; Gilleece, Yvonne; Kirk, Sarah; Nelson, Mark; Housman, Rosalie; Miras, Helena; Orkin, Chloe; Fox, Ashini; Curnock, Michael; Jennings, Louise; Gompels, Mark; Clarke, Emily; Robinson, Rachel; Lambert, Pauline; Chadwick, David; Perry, Nicky.
Afiliação
  • Bradshaw D; The Lawson Unit, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom.
  • Abramowicz I; Brighton and Sussex Clinical Trials Unit, University of Sussex, Brighton, United Kingdom.
  • Bremner S; Brighton and Sussex Clinical Trials Unit, University of Sussex, Brighton, United Kingdom.
  • Verma S; Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom.
  • Gilleece Y; Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom.
  • Kirk S; The Lawson Unit, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom.
  • Nelson M; The Lawson Unit, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom.
  • Housman R; Department of HIV and Sexual Health, Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom.
  • Miras H; Department of HIV and Sexual Health, Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom.
  • Orkin C; Grahame Hayton Unit, Barts Health NHS Trust, London, United Kingdom.
  • Fox A; Grahame Hayton Unit, Barts Health NHS Trust, London, United Kingdom.
  • Curnock M; Department of Genitourinary Medicine and HIV, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Jennings L; Department of Genitourinary Medicine and HIV, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Gompels M; Department of HIV, North Bristol NHS Trust, Bristol, United Kingdom.
  • Clarke E; Department of HIV, North Bristol NHS Trust, Bristol, United Kingdom.
  • Robinson R; Department of Genitourinary Medicine and HIV, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
  • Lambert P; Department of Genitourinary Medicine and HIV, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
  • Chadwick D; Department of Infectious Diseases, South Tees Hospitals NHS Foundation Trust, Middlesbrough, United Kingdom.
  • Perry N; Department of Infectious Diseases, South Tees Hospitals NHS Foundation Trust, Middlesbrough, United Kingdom.
PLoS One ; 18(7): e0288598, 2023.
Article em En | MEDLINE | ID: mdl-37450478
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Diabetes Mellitus Tipo 2 / Técnicas de Imagem por Elasticidade / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Female / Humans / Male Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Diabetes Mellitus Tipo 2 / Técnicas de Imagem por Elasticidade / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Female / Humans / Male Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido